샘플 요청 목록

 카트 문의
시장보고서
상품코드
2148166

피임약 시장

Contraceptives
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 425 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,834,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 14,886,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,504,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 피임약 시장은 2032년까지 285억 달러에 달할 전망

2025년에 203억 달러로 추정되는 세계의 피임약 시장은 2025년부터 2032년까지의 분석 기간 동안 CAGR 5.0%로 성장하여, 2032년까지 285억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석 대상이 되고 있는 부문 중 하나인 의약품은 CAGR 6.0%를 기록하며 분석 기간 종료까지 186억 달러에 달할 것으로 전망됩니다. 의료기기 부문의 성장률은 분석 기간 중 CAGR 3.3%로 추정됩니다.

미국 시장은 55억 달러로 추정되는 한편 중국은 CAGR 8.8%로 성장할 것으로 예측

2025년 미국의 피임약 시장 규모는 55억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025년부터 2032년까지의 분석 기간 동안 CAGR 8.8%를 기록하며 2032년까지 시장 규모가 61억 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안에 각각 CAGR 2.2% 및 4.0%로 성장할 것으로 예측됩니다. 유럽내에서는 독일이 CAGR 약 3.2%로 성장할 것으로 예측됩니다.

세계의 피임약 시장 - 주요 동향과 촉진요인 개요

피임약은 배란, 수정 또는 착상의 정상적인 과정을 방해하여 임신을 방지하도록 설계된 의료 제품입니다. 경구 피임약, 콘돔, 자궁 내 피임 장치(IUD), 임플란트, 주사제, 패치, 응급 피임약 등 다양한 형태가 있습니다. 각 방법에는 개인의 건강 상태나 선호도에 따라 서로 다른 유효성, 작용 지속 시간, 적합성이 있습니다. 피임약 시장은 몇 가지 주요 요인에 의해 견인되고 있습니다. 중요한 촉진요인 중 하나는 성 건강 및 가족 계획에 대한 인식 제고와 교육의 발전입니다. 정부와 비정부기구(NGO)가 공중보건 캠페인 및 교육 프로그램에 투자함에 따라, 피임법의 이점과 접근성에 대해 아는 사람들이 늘어나고 있습니다. 이러한 인식 제고로 인해 사람들이 자신의 생식 건강을 스스로 관리하려 하게 되면서 피임법 채택률이 높아지고 있습니다. 또한, 각국 정부의 우대 정책이나 보조금과 같은 지원 확대에 따라 피임법에 대한 접근성이 용이해지고, 합리적인 가격에 구입할 수 있게 된 점도 시장 성장을 더욱 뒷받침하고 있습니다.

피임 분야는 새로운 방법의 개발과 기존 방법의 개선에 따라 끊임없이 진화하고 있습니다. IUD(자궁 내 피임 기구)나 임플란트 등 장기 작용형 가역적 피임법(LARCs)에 대한 수요가 증가하고 있습니다. 이러한 방법은 피임약이나 콘돔 등 단기적인 방법과 비교하여 높은 유효성과 편의성, 그리고 작용 기간이 길다는 점에서 점점 더 인기를 얻고 있습니다. 또한, 기술의 발전으로 인해 사용 편의성이 향상되고 부작용이 적은, 새롭게 개선된 피임법들이 개발되고 있습니다. 예를 들어, 호르몬 패치나 질 내 링의 등장은 더 유연하고 사용하기 쉬운 선택지를 제공하며, 더 많은 사람들이 이러한 대안을 고려하도록 유도하고 있습니다.

전 세계적으로 피임 도구 사용이 증가하고 있으며, 이는 세계 생식 건강 분야에서 긍정적인 변화를 보여줍니다. 피임 시장의 소비자 선호도 또한 임신 예방 외에도 건강상의 이점을 제공하는 제품으로 점차 이동하고 있습니다. 예를 들어, 일부 경구 피임약은 과다월경이나 심한 생리통과 같은 월경 관련 문제를 완화하도록 설계되어 사용자에게 더 매력적인 선택지가 되고 있습니다. 또한, E-Commerce 플랫폼과 원격의료 서비스의 부상으로 피임약에 대한 접근 및 구매 방식에 혁명적인 변화가 일어나고 있습니다. 이러한 디지털 채널은 특히 외딴 지역이나 의료 서비스가 미비한 지역에 거주하는 사람들에게 더 높은 사생활 보호, 편의성 및 접근성을 제공하고 있습니다. 그 결과, 피임약 시장은 더 폭넓은 계층으로 확대되고 있으며, 이는 시장의 지속적인 성장과 발전에 기여하고 있습니다.

부문 :

제품별(의약품, 의료기기), 성별(여성, 남성), 유통 채널(병원·진료소, 슈퍼마켓/하이퍼마켓, 소매 약국, 드럭스토어, 온라인)

주요 기업

  • Agile Therapeutics, Inc.
  • Allergan plc
  • Ansell Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical Inc.
  • Fuji Latex Co. Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Mankind Pharma Ltd.
  • Okamoto Industries, Inc.
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc.
  • Sagami Rubber Industries Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thai Nippon Rubber Industry Co., Ltd.

해당 분야의 전문가 관점에 기반 - 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용 - 컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업의 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보 출처에서 얻은 인사이트를 통합합니다.

신호와 전략적 시장 방향성을 연결 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 높은 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 면밀히 검토합니다.

주요 지역의 시장 점유율 분석 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구조는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞춰 상세도를 조정하여 주요 지역의 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 26.10.21

Global Contraceptives Market to Reach US$28.5 Billion by 2032

The global market for Contraceptives estimated at US$20.3 Billion in the year 2025, is expected to reach US$28.5 Billion by 2032, growing at a CAGR of 5.0% over the analysis period 2025-2032. Drugs Offering, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$18.6 Billion by the end of the analysis period. Growth in the Devices Offering segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 8.8% CAGR

The Contraceptives market in the U.S. is estimated at US$5.5 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2032 trailing a CAGR of 8.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Contraceptives Market - Key Trends and Drivers Summarized

Contraceptives are medical products designed to prevent pregnancy by interfering with the normal process of ovulation, fertilization, or implantation. They come in various forms, including oral pills, condoms, intrauterine devices (IUDs), implants, injectables, patches, and emergency contraception pills. Each method offers different levels of effectiveness, durations of action, and suitability based on individual health profiles and preferences. The contraceptive market is driven by several key factors. One significant driver is the increasing awareness and education regarding sexual health and family planning. As governments and non-governmental organizations (NGOs) invest in public health campaigns and educational programs, more individuals are informed about the benefits and availability of contraceptives. This heightened awareness leads to higher adoption rates as people seek to take control of their reproductive health. Additionally, the growing support from various governments in the form of favorable policies and subsidies makes contraceptives more accessible and affordable, further boosting market growth.

The landscape of contraception is constantly evolving with the development of new methods and the extension of existing ones. There is a rising demand for long-acting reversible contraceptives (LARCs) such as IUDs and implants. These methods are becoming increasingly popular due to their high efficacy, convenience, and longer duration of action compared to short-term methods such as pills or condoms. Moreover, technological advancements are leading to the development of new and improved contraceptive options that offer better user experiences and fewer side effects. For instance, the advent of hormonal patches and vaginal rings provides more flexibility and ease of use, encouraging more individuals to consider these alternatives.

Contraceptive use is increasing worldwide, marking a positive shift in global reproductive health. Consumer preferences in the contraceptive market are also shifting towards products that offer additional health benefits beyond pregnancy prevention. For instance, some contraceptive pills are designed to alleviate menstrual-related issues such as heavy bleeding and severe cramps, making them more attractive to users. Furthermore, the rise of e-commerce platforms and telemedicine services is revolutionizing the way contraceptives are accessed and purchased. These digital channels provide greater privacy, convenience, and accessibility, particularly for individuals in remote or underserved areas. As a result, the contraceptive market is expanding to reach a broader audience, contributing to its sustained growth and development.

SCOPE OF STUDY:

The report analyzes the Contraceptives market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Drugs Offering, Devices Offering); Gender (Female Gender, Male Gender); Distribution Channel (Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Agile Therapeutics, Inc.
  • Allergan plc
  • Ansell Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical Inc.
  • Fuji Latex Co. Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Mankind Pharma Ltd.
  • Okamoto Industries, Inc.
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc.
  • Sagami Rubber Industries Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thai Nippon Rubber Industry Co., Ltd.

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Contraceptives: Transforming Birth Control, Planned Parenthood, and Women's Health
    • Contraceptives Market: Fast Facts
    • The Vital Need to Curtail the Ballooning Global Population through Birth Control:
    • Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy Percentage, Benefits, Risks, and Availability
    • Unmet Contraception Needs Signals Huge Market Penetration Opportunities
    • Global Population Statistics: Unfurling the Market Potential
    • Global Market Outlook
    • Contraceptives - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 92 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in Demand
    • Condoms: Percentage Effectiveness of Protection against STDs
    • Contraceptive Innovations and Advancements: Spearheading Growth
    • Major Condom Innovations
    • Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion
    • Rising Need to Develop Contraceptives for Men Drive Robust Research & Development
    • Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing Adoption
    • Increasing Standard of Living: A Key Growth Driver
    • Social Stigmas in Under Developed Countries Hamper Market Prospects
    • Major Hindrances for Widespread Usages of Condoms
    • Developing Countries Continue to Drive Current and Future Market Growth
    • Manufacturers Depend on Emerging Markets to Increase Sales Momentum
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contraceptives Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Drugs Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Drugs Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Drugs Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Devices Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Devices Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Devices Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Hospitals & Clinics Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Supermarkets / Hypermarkets Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Supermarkets / Hypermarkets Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Supermarkets / Hypermarkets Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 33: USA Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: USA 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 35: USA Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 36: USA Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: USA 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 38: USA Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: USA Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: USA 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: Canada Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: Canada 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: Canada Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: Canada 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: Canada Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: Canada 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • JAPAN
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Japan Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: Japan 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Japan Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Japan 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Japan Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: Japan 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • CHINA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: China Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: China 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 62: China Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: China Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: China 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 65: China Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: China Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: China 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • EUROPE
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Europe Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: Europe 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 72: Europe Historic Review for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: Europe 13-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Europe Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Europe 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: Europe Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: Europe 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • FRANCE
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: France Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: France 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 83: France Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: France Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: France 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 86: France Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: France Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: France 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • GERMANY
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Germany Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: Germany 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Germany Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: Germany 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Germany Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Germany 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Italy Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Italy 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Italy Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Italy 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: Italy Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: Italy 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: UK Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: UK 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 110: UK Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: UK Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: UK 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 113: UK Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: UK Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: UK 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Spain Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: Spain 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Spain Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: Spain 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Spain Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Spain 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Russia Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Russia 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Russia Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Russia 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Russia Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Russia 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Rest of Europe 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Rest of Europe 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: Rest of Europe 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: Asia-Pacific 13-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: Asia-Pacific 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: Asia-Pacific 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Asia-Pacific 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Australia Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Australia 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Australia Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Australia 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Australia Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Australia 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • INDIA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: India Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: India 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 167: India Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: India Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: India 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 170: India Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: India Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: India 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: South Korea Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: South Korea 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: South Korea Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: South Korea 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: South Korea Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: South Korea 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Latin America Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Latin America 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 195: Latin America Historic Review for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Latin America 13-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Latin America Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Latin America 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Latin America Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Latin America 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Argentina Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Argentina 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Argentina Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Argentina 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Argentina Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Argentina 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Brazil Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Brazil 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: Brazil Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: Brazil 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: Brazil Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: Brazil 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: Mexico Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: Mexico 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: Mexico Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: Mexico 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: Mexico Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: Mexico 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: Rest of Latin America 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: Rest of Latin America 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: Rest of Latin America 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Middle East Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Middle East 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 243: Middle East Historic Review for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Middle East 13-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Middle East Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Middle East 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Middle East Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Middle East 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 252: Iran Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Iran 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Iran Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Iran 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Iran Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Iran 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Israel Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Israel 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Israel Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Israel 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Israel Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Israel 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Saudi Arabia 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Saudi Arabia 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Saudi Arabia 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: UAE Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: UAE 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: UAE Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: UAE 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: UAE Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: UAE 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Rest of Middle East 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Rest of Middle East 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Rest of Middle East 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032
  • AFRICA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Contraceptives by Gender - Female Gender and Male Gender - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Africa Historic Review for Contraceptives by Gender - Female Gender and Male Gender Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Africa 13-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female Gender and Male Gender for the Years 2020, 2026 & 2032
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Contraceptives by Offering - Drugs Offering and Devices Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Africa Historic Review for Contraceptives by Offering - Drugs Offering and Devices Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Africa 13-Year Perspective for Contraceptives by Offering - Percentage Breakdown of Value Sales for Drugs Offering and Devices Offering for the Years 2020, 2026 & 2032
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Africa Historic Review for Contraceptives by Distribution Channel - Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Africa 13-Year Perspective for Contraceptives by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals & Clinics Distribution Channel, Supermarkets / Hypermarkets Distribution Channel, Retail Pharmacies Distribution Channel, Drug Stores Distribution Channel and Online Distribution Channel for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기